Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 14Rectal Neoplasms 13Colonic Neoplasms 10Esophageal Neoplasms 5Stomach Neoplasms 4Rhabdomyosarcoma 4Pancreatic Neoplasms 4Neuroblastoma 4Central Nervous System Neoplasms 4Adenocarcinoma Of Esophagus 4Sarcoma 3Neoplasm Metastasis 3Medulloblastoma 3Lung Neoplasms 3Wilms Tumor 2Unspecified Childhood Solid Tumor, Protocol Specific 2Sarcoma, Ewing 2Ovarian Neoplasms 2Optic Nerve Glioma 2Oligodendroglioma 2Malignant mesenchymal tumor 2Fibrolamellar hepatocellular carcinoma 2Familial ependymoma 2Esophageal Squamous Cell Carcinoma 2Choroid Plexus Neoplasms 2Astrocytoma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1

Interventions

Cisplatin 4Paclitaxel 3Docetaxel 3Taxes 2Radiotherapy, Conformal 2Polymerase Chain Reaction 2Immunohistochemistry 2Gene Expression Profiling 2Gemcitabine 2Carboplatin 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1mercaptoundecahydrododecaborate 1bicalutamide 1Vorinostat 1Triptorelin Pamoate 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Pilocarpine 1Methotrexate 1Irinotecan 1In Situ Hybridization 1Erlotinib Hydrochloride 1Doxorubicin 1Chemotherapy, Adjuvant 1CP protocol 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 14-boronophenylalanine-fructose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Salivary Gland Neoplasms × Irinotecan × Clear all
NCT00040807 2023-06-18

Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡